The COVID-19 pandemic has strengthened the interest in the biological mechanisms
underlying the complex interplay between infectious agents and the human host. The …

A new global pandemic of coronavirus disease 2019 (COVID-19) has resulted in high
mortality and morbidity. Currently numerous drugs are under expedited investigations …

Rheumatoid arthritis (RA) is the most common inflammatory arthropathy worldwide. Possible
manifestations of RA can be represented by a wide variability of symptoms, clinical forms …

COVID-19 presentation is very heterogeneous across cases, and host factors are at the
forefront for the variables affecting the disease manifestation. The immune system has …

In December 2019, the severe acute respiratory syndrome virus‐2 pandemic began,
causing the coronavirus disease 2019. A vast variety of drugs is being used off‐label as …

Introduction: Rheumatoid arthritis (RA) is an autoimmune disease that is characterized by
chronic inflammation of the joints and affects 1% of the population. Polymorphisms of genes …

Rheumatoid arthritis (RA) is a systemic disease that leads to joint destruction. During the last
decade, the therapy of RA has been principally based on biological drugs. Although the …

Abatacept (ABA) is used as a first-line treatment in patients diagnosed with moderate and
severe rheumatoid arthritis (RA). The interindividual response to ABA therapy is very …

Relevance. A variety of targeted therapies for rheumatoid arthritis (RA) treatment exist.
Therefore, reliable predictors are needed that could be used to accurately predict the …

Abstract Interleukin-6 (IL6) expression increases in atrophying muscles and lung tissue
during compromised function. Considering ALS patients undergo these same pathological …